Bold Capital
QuietFiled to raiseSanta Monica, CABiotechnology, Healthcare, EnergyLast fund filed 2025
3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| BOLD Capital Partners SX2Filed to raise in 2025, with no closing reported yet. | 2025 | $20M | $0 | 0 |
| BOLD Capital Associates IIIFiled to raise in 2022, with no closing reported yet. | 2022 | $6.1M | $0 | 0 |
| BOLD Capital Partners IIIFiled to raise in 2021, with no closing reported yet. | 2021 | $250M | $0 | 0 |
| BOLD Capital SelectFiled to raise in 2020, with no closing reported yet. | 2020 | $100M | $0 | 0 |
| BOLD Capital Partners IIFiled to raise in 2017, with no closing reported yet. | 2017 | $200M | $0 | 0 |
| Bold Capital Partners S2Filed to raise in 2016, with no closing reported yet. | 2016 | Indefinite | $0 | 0 |
| Bold Capital PartnersFiled to raise in 2015, with no closing reported yet. | 2015 | $200M | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Emilio Barroso | Quiet | None listed | 0 | 0 |
| Neal Bhadkamkar | Quiet | Biotech & pharma, Enterprise software, Logistics & supply chain | 5 | 0 |
| Peter DiamandisNot on the current fund | Quiet | Biotech & pharma, Healthcare services, Aerospace & defense | 14 | 0 |
| Teymour Boutros-Ghali | Quiet | Biotech & pharma, Climate & energy, Digital health | 6 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Bold Capital’s own portfolio companies, based on 23 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Bold Capital’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| NEW York Life Insurance | 2 | Singularity Education Group, VIOME LIFE SCIENCES |
| Cota | 1 | Cloudleaf |
| Cota Capital Institutional Partners | 1 | Cloudleaf |
| Cota Capital Partners | 1 | Cloudleaf |
| Cota Enterprise Ventures | 1 | Cloudleaf |
| Cota Fintech Ventures | 1 | Cloudleaf |
| Formation8 Partners | 1 | Hyperloop Technologies |
| Kendall Capital Partners | 1 | SYNTIS BIO |
| Kodiak | 1 | Hyperloop Technologies |
| M13 | 1 | Lifeforce Digital |
| Wrvi Capital | 1 | Cloudleaf |
A shared board seat: a company where filings name a Bold Capital partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.